Clinical Trial Update: Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

View source ↗

Summary

This clinical trial update reports patient-reported changes in the burden of hidradenitis suppurativa after initiation of secukinumab, in a Novartis-sponsored s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hidradenitis Suppurativa | Status: ACTIVE_NOT_RECRUITING